THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED The United Laboratories International Holdings Limited Share Price
Equities
3933
KYG8813K1085
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.48 HKD | -2.97% |
|
-1.15% | +35.24% |
| Sales 2023 | 14.89B 1.9B 152B | Sales 2024 * | 15.82B 2.02B 162B | Capitalization | 17.23B 2.2B 176B |
|---|---|---|---|---|---|
| Net income 2023 | 2.93B 374M 29.94B | Net income 2024 * | 2.94B 376M 30.09B | EV / Sales 2023 | 0.65 x |
| Net cash position 2023 | 2.99B 382M 30.61B | Net cash position 2024 * | 7.07B 904M 72.36B | EV / Sales 2024 * | 0.64 x |
| P/E ratio 2023 |
4.35
x | P/E ratio 2024 * |
5.86
x | Employees | 15,000 |
| Yield 2023 |
6.18% | Yield 2024 * |
3.76% | Free-Float | 53.17% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.97% | ||
| 1 week | -1.15% | ||
| Current month | +5.80% | ||
| 1 month | -2.37% | ||
| 3 months | +37.19% | ||
| 6 months | +25.07% | ||
| Current year | +35.24% |
1 week
9.10
9.79
1 month
8.6410.24
Current year
6.5610.24
1 year
5.6910.24
3 years
3.1710.24
5 years
3.1710.24
10 years
2.7010.24
| Managers | Title | Age | Since |
|---|---|---|---|
Hoi Shan Tsoi
CHM | Chairman | 46 | 02/04/10 |
Wing Hon Leung
DFI | Director of Finance/CFO | 62 | - |
Yu Ping Fang
BRD | Director/Board Member | 61 | 31/10/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Song
BRD | Director/Board Member | 62 | 24/05/07 |
Siu Chit Choy
BRD | Director/Board Member | 52 | 24/05/07 |
Wing Hon Leung
DFI | Director of Finance/CFO | 62 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 9.48 | -2.97% | 6,034,388 |
| 25/04/24 | 9.77 | +4.05% | 3,180,388 |
| 24/04/24 | 9.39 | +0.11% | 3,927,388 |
| 23/04/24 | 9.38 | +0.43% | 2,026,388 |
| 22/04/24 | 9.34 | -2.61% | 4,154,388 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
Sector
Pharmaceuticals
Calendar
16/06/2024
- Ex-dividend day for extraordinary dividend
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
9.48
HKD
Average target price
12.12
HKD
Spread / Average Target
+27.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +35.24% | 2.2B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 3933 Stock
